Elite Pharmaceuticals, Inc. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Elite Pharmaceuticals, Inc. (ELTP) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $1.18 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $1.18M.
- 2026-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $1.30M.
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $1.41M.
- 2025-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $1.53M.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2026-06-30 | $1.18M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.30M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $1.41M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $1.53M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.65M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.77M 10-K · filed 2026-06-29 |
| 2024-12-31 | $1.89M 10-Q · filed 2025-02-13 |
| 2024-09-30 | $2.01M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.98M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.08M 10-K · filed 2025-06-30 |
| 2023-12-31 | $408.43K 10-Q · filed 2024-02-14 |